High expression of S100A2 predicts poor prognosis in patients with endometrial carcinoma

BACKGROUND: S100A2, a member of the S100 protein family, is abnormally expressed and plays a vital role in multiple cancers. However, little is known about the clinical significance of S100A2 in endometrial carcinoma. METHODS: Clinicopathological data were obtained from The Cancer Genome Atlas (TCGA...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qinzhen, Xia, Tianxiang, Qi, Chenxiang, Du, Jun, Ye, Chunping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764844/
https://www.ncbi.nlm.nih.gov/pubmed/35042454
http://dx.doi.org/10.1186/s12885-022-09180-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764844/
https://www.ncbi.nlm.nih.gov/pubmed/35042454
http://dx.doi.org/10.1186/s12885-022-09180-5

Ejemplares similares